Graves' disease: Epidemiology, genetic and environmental risk factors and viruses

A Antonelli, SM Ferrari, F Ragusa, G Elia… - Best practice & research …, 2020 - Elsevier
Graves' disease (GD) is the most common cause of hyperthyroidism in developed Countries.
It is more common between 30 and 60 years; 5–10 times more frequent in women. The …

The interplay between thyroid and liver: implications for clinical practice

E Piantanida, S Ippolito, D Gallo, E Masiello… - Journal of …, 2020 - Springer
A complex relationship exists between thyroid and liver in health and disease. Liver plays an
essential physiological role in thyroid hormone activation and inactivation, transport, and …

Extrahepatic manifestations of chronic hepatitis C

P Cacoub, T Poynard, P Ghillani… - … : Official Journal of …, 1999 - Wiley Online Library
Objective To assess the prevalence of clinical and biologic extrahepatic manifestations of
hepatitis C virus (HCV) infection and to identify associations between clinical and biologic …

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

SH Mehta, FL Brancati, MS Sulkowski… - Annals of internal …, 2000 - acpjournals.org
Background: Hepatitis C virus (HCV) infection may contribute to the development of diabetes
mellitus. This relationship has not been investigated at the population level, and its …

Environmental issues in thyroid diseases

SM Ferrari, P Fallahi, A Antonelli… - Frontiers in …, 2017 - frontiersin.org
Environmental factors are determinant for the appearance of autoimmune thyroid diseases
(AITD) in susceptible subjects. Increased iodine intake, selenium, and vitamin D deficiency …

The etiology of autoimmune thyroid disease: a story of genes and environment

Y Tomer, A Huber - Journal of autoimmunity, 2009 - Elsevier
Autoimmune thyroid diseases (AITDs), including Graves' disease (GD) and Hashimoto's
thyroiditis (HT) are prevalent autoimmune diseases, affecting up to 5% of the general …

Hepatitis C: a multifaceted disease: review of extrahepatic manifestations

SC Gumber, S Chopra - Annals of internal medicine, 1995 - acpjournals.org
Purpose: To review the available data on the association between hepatitis C virus (HCV)
infection and conditions reportedly related to infection with the virus and to assess the …

A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon

G Fattovich, G Giustina, S Favarato, A Ruol - Journal of hepatology, 1996 - Elsevier
Aims: The aim of this study was to assess the incidence of fatal, life-threatening side effects
and the de novo appearance of non-hepatic morbidity during interferon alfa therapy for …

Side effects of high-dose interferon therapy for chronic hepatitis C

T Okanoue, S Sakamoto, Y Itoh, M Minami, K Yasui… - Journal of …, 1996 - Elsevier
Background/Aims: Various side effects have been reported in patients treated with alpha
interferon, but their incidence and prognosis remain unknown. Methods: Nine hundred and …

[PDF][PDF] Is an “à la carte” combination interferon alfa‐2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?

T Poynard, J McHutchison, Z Goodman, MH Ling… - …, 2000 - Wiley Online Library
Randomized trials have shown the enhancement of efficacy with interferon alfa‐2b and
ribavirin (IFN‐R) in comparison with interferon monotherapy (IFN) as first line treatment of …